# Efficacy of PMZ-2010 (Centhaquine) a Resuscitative Agent for Hypovolemic Shock

> **NCT04045327** · PHASE3 · COMPLETED · sponsor: **Pharmazz, Inc.** · enrollment: 105 (actual)

## Conditions studied

- Hypovolemic Shock

## Interventions

- **DRUG:** Normal saline + Standard Treatment
- **DRUG:** Centhaquine + Standard Treatment

## Key facts

- **NCT ID:** NCT04045327
- **Lead sponsor:** Pharmazz, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-01-31
- **Primary completion:** 2019-09-23
- **Final completion:** 2019-09-27
- **Target enrollment:** 105 (ACTUAL)
- **Last updated:** 2019-10-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04045327

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04045327, "Efficacy of PMZ-2010 (Centhaquine) a Resuscitative Agent for Hypovolemic Shock". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04045327. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*